Literature DB >> 10404693

Association of angiotensin-converting enzyme gene polymorphism and renal pathology in Japanese children with IgA nephropathy.

T Asano1, N Tatsuma, J Yoshida, R Ohashi, K Ambo, M Tsuchiya, M Murakami, N Yamanaka, M Honda, M Yamamoto.   

Abstract

Polymorphism of the gene that codes for angiotensin I-converting enzyme (ACE) is associated with increased severity of immunoglobulin A (IgA) nephropathy in adult patients. We evaluated the relationship between the polymorphism of ACE genotypes and the pathological and clinical findings in Japanese children with IgA nephropathy. Patients with moderate/diffuse mesangial proliferation, glomerular sclerosis and tubulointerstitial damage showed a significant increase of the D/D type compared to those who had mild/focal mesangial proliferation, without glomerular sclerosis or tubulointerstitial damage (p < 0.05). Proteinuria at the first renal biopsy was significantly higher in the former group compared with the latter group except glomerular sclerosis (p < 0.01). IgA nephropathy patients with tubulointerstitial damage also showed an increased serum creatinine level compared to patients without the damage (p < 0.03). We conclude that ACE gene polymorphism may be correlated with the prognosis of IgA nephropathy in Japanese children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404693

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  2 in total

1.  Primary IgA nephropathy in children: association of clinical and pathological findings with prognosis.

Authors:  F Genel; S Arslanoğlu; B Durmaz; M Bak
Journal:  Indian J Pediatr       Date:  2001-05       Impact factor: 1.967

2.  Renin-angiotensin system polymorphisms and renal scarring.

Authors:  Rafael Pardo; Serafín Málaga; Eliecer Coto; Mercedes Navarro; Victoria Alvarez; Laura Espinosa; Ruth Alvarez; Alfredo Vallo; Cesar Loris; Socorro Braga
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.